Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters

T. T. Böhlen, S. Brons, M. Dosanjh, A. Ferrari, P. Fossati, T. Haberer, V. Patera, A. Mairani

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion beam therapy carry the risk of absolute and relative misestimations of RBE-weighted doses for clinical scenarios. This study assesses the consequences of hypothetical misestimations of input parameters to the RBE modelling for carbon ion treatment plans by a variational approach. The impact of the variations on resulting cell survival and RBE values is evaluated as a function of the remaining ion range. In addition, the sensitivity to misestimations in RBE modelling is compared for single fields and two opposed fields using differing optimization criteria. It is demonstrated for single treatment fields that moderate variations (up to ±50%) of representative nominal input parameters for four tumours result mainly in a misestimation of the RBE-weighted dose in the planning target volume (PTV) by a constant factor and only smaller RBE-weighted dose gradients. Ensuring a more uniform radiation quality in the PTV eases the clinical importance of uncertainties in the radiobiological treatment parameters, as for such a condition uncertainties tend to result only in a systematic misestimation of RBE-weighted dose in the PTV by a constant factor. Two opposed carbon ion fields with a constant RBE in the PTV are found to result in rather robust conditions. Treatments using two ion species may be used to achieve a constant RBE in the PTV irrespective of the size and depth of the spread-out Bragg peak.

Original languageEnglish
Pages (from-to)7983-8004
Number of pages22
JournalPhysics in Medicine and Biology
Volume57
Issue number23
DOIs
Publication statusPublished - Dec 7 2012

Fingerprint

Relative Biological Effectiveness
Uncertainty
Ions
Therapeutics
Carbon
Cell Survival

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters. / Böhlen, T. T.; Brons, S.; Dosanjh, M.; Ferrari, A.; Fossati, P.; Haberer, T.; Patera, V.; Mairani, A.

In: Physics in Medicine and Biology, Vol. 57, No. 23, 07.12.2012, p. 7983-8004.

Research output: Contribution to journalArticle

Böhlen, T. T. ; Brons, S. ; Dosanjh, M. ; Ferrari, A. ; Fossati, P. ; Haberer, T. ; Patera, V. ; Mairani, A. / Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters. In: Physics in Medicine and Biology. 2012 ; Vol. 57, No. 23. pp. 7983-8004.
@article{76532537c1254a72bde4a94b60cfe3d2,
title = "Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters",
abstract = "Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion beam therapy carry the risk of absolute and relative misestimations of RBE-weighted doses for clinical scenarios. This study assesses the consequences of hypothetical misestimations of input parameters to the RBE modelling for carbon ion treatment plans by a variational approach. The impact of the variations on resulting cell survival and RBE values is evaluated as a function of the remaining ion range. In addition, the sensitivity to misestimations in RBE modelling is compared for single fields and two opposed fields using differing optimization criteria. It is demonstrated for single treatment fields that moderate variations (up to ±50{\%}) of representative nominal input parameters for four tumours result mainly in a misestimation of the RBE-weighted dose in the planning target volume (PTV) by a constant factor and only smaller RBE-weighted dose gradients. Ensuring a more uniform radiation quality in the PTV eases the clinical importance of uncertainties in the radiobiological treatment parameters, as for such a condition uncertainties tend to result only in a systematic misestimation of RBE-weighted dose in the PTV by a constant factor. Two opposed carbon ion fields with a constant RBE in the PTV are found to result in rather robust conditions. Treatments using two ion species may be used to achieve a constant RBE in the PTV irrespective of the size and depth of the spread-out Bragg peak.",
author = "B{\"o}hlen, {T. T.} and S. Brons and M. Dosanjh and A. Ferrari and P. Fossati and T. Haberer and V. Patera and A. Mairani",
year = "2012",
month = "12",
day = "7",
doi = "10.1088/0031-9155/57/23/7983",
language = "English",
volume = "57",
pages = "7983--8004",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "23",

}

TY - JOUR

T1 - Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters

AU - Böhlen, T. T.

AU - Brons, S.

AU - Dosanjh, M.

AU - Ferrari, A.

AU - Fossati, P.

AU - Haberer, T.

AU - Patera, V.

AU - Mairani, A.

PY - 2012/12/7

Y1 - 2012/12/7

N2 - Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion beam therapy carry the risk of absolute and relative misestimations of RBE-weighted doses for clinical scenarios. This study assesses the consequences of hypothetical misestimations of input parameters to the RBE modelling for carbon ion treatment plans by a variational approach. The impact of the variations on resulting cell survival and RBE values is evaluated as a function of the remaining ion range. In addition, the sensitivity to misestimations in RBE modelling is compared for single fields and two opposed fields using differing optimization criteria. It is demonstrated for single treatment fields that moderate variations (up to ±50%) of representative nominal input parameters for four tumours result mainly in a misestimation of the RBE-weighted dose in the planning target volume (PTV) by a constant factor and only smaller RBE-weighted dose gradients. Ensuring a more uniform radiation quality in the PTV eases the clinical importance of uncertainties in the radiobiological treatment parameters, as for such a condition uncertainties tend to result only in a systematic misestimation of RBE-weighted dose in the PTV by a constant factor. Two opposed carbon ion fields with a constant RBE in the PTV are found to result in rather robust conditions. Treatments using two ion species may be used to achieve a constant RBE in the PTV irrespective of the size and depth of the spread-out Bragg peak.

AB - Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion beam therapy carry the risk of absolute and relative misestimations of RBE-weighted doses for clinical scenarios. This study assesses the consequences of hypothetical misestimations of input parameters to the RBE modelling for carbon ion treatment plans by a variational approach. The impact of the variations on resulting cell survival and RBE values is evaluated as a function of the remaining ion range. In addition, the sensitivity to misestimations in RBE modelling is compared for single fields and two opposed fields using differing optimization criteria. It is demonstrated for single treatment fields that moderate variations (up to ±50%) of representative nominal input parameters for four tumours result mainly in a misestimation of the RBE-weighted dose in the planning target volume (PTV) by a constant factor and only smaller RBE-weighted dose gradients. Ensuring a more uniform radiation quality in the PTV eases the clinical importance of uncertainties in the radiobiological treatment parameters, as for such a condition uncertainties tend to result only in a systematic misestimation of RBE-weighted dose in the PTV by a constant factor. Two opposed carbon ion fields with a constant RBE in the PTV are found to result in rather robust conditions. Treatments using two ion species may be used to achieve a constant RBE in the PTV irrespective of the size and depth of the spread-out Bragg peak.

UR - http://www.scopus.com/inward/record.url?scp=84870342065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870342065&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/57/23/7983

DO - 10.1088/0031-9155/57/23/7983

M3 - Article

VL - 57

SP - 7983

EP - 8004

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 23

ER -